Drreddys Laboratories | RDY - Loan Capital


Drreddys Laboratories reported INR12.2B in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
ANI Pharmaceuticals USD 280.15M 5.84M Jun/2026
Aurora Cannabis CAD 18.13M 15.07M Mar/2026
Bayer EUR 30.68B 1.15B Mar/2026
Canopy Growth CAD 217.12M 7.87M Mar/2026
Cipla INR 3.82B 840.2M Mar/2026
Drreddys Laboratories INR 12.2B 12.07B Mar/2026
GlaxoSmithKline GBP 13.95B 65M Jun/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Lonza CHF 3.88B 323M Dec/2025
Novartis USD 37.49B 42M Jun/2026
Pacira USD 363.12M 4.53M Jun/2026
Phibro Animal Health USD 597.68M 5.92M Mar/2026
Prestige Brands USD 2.02B 1.01B Jun/2026
Richter Gedeon HUF 15.07B 75M Mar/2026
Sun Pharmaceuticals INR 3.93B 309.9M Mar/2026
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Teva Pharmaceutical Industries USD 12.09B 1.92B Jun/2026